Applied Evidence

Tips for treating patients with late-life depression

Author and Disclosure Information

 

References

The role of aripiprazole. Elderly patients not achieving remission from depression with antidepressant agents alone may benefit from co-prescribing aripiprazole.32 As an adjunct, aripiprazole is effective in achieving and sustaining remission, but it has the potential for less tolerability by inducing akathisia and parkinsonism.32

Minimize risks and maximize ­benefits of antidepressants by following these recommendations:

  1. Ascertain whether any antidepressant treatments have worked well in the past.
  2. Start with an SSRI if no other antidepressant treatment has worked in the past.
  3. Counsel patients about the need for treatment adherence. Antidepressants may take 2 weeks to 2 months to provide noticeable improvement.
  4. Prescribe up to the maximum drug dose if needed to enhance benefit.
  5. Use a mood measurement tool (eg, the Patient Health Questionnaire-9) to help evaluate treatment response.

Try a different class of drugs for patients who do not respond to treatment. For patients who have a partial response, augment with bupropion XL, mirtazapine, aripiprazole, or quetiapine.33 Sertraline and nortriptyline are similarly effective on a population-wide basis, with sertraline having less-problematic adverse effects.34 Trial-and-error treatments in practice may find one patient responding only to sertraline and another patient only to nortriptyline.

Transcranial magnetic stimulation is a promising, relatively new therapeutic option for treating refractory cases of depressive mood disorders.

Combinations of different drug classes may provide benefit for patients not responding to a single antidepressant. In geriatric patients, combined treatment with methylphenidate and citalopram enhances mood and well-being.35 Compared with either drug alone, the combination yielded an augmented clinical response profile and a higher rate of remission. Cognitive functioning, energy, and mood improve even with methylphenidate alone, especially when fatigue is an issue. However, addictive properties limit its use to cases in which conventional antidepressant medications are not effective or indicated, and only when drug refills are closely monitored.

The challenges of advancing age. Antidepressant treatment needs increase with advanced age.36 As mentioned earlier, elderly people often have medical illnesses complicating their depression and frequently are dealing with pain from the medical illness. When dementia coexists with depression, the efficacy of pharmacotherapies is compromised.

Continue to: When drug-related interventions fail

Pages

Recommended Reading

Distinct suicidal thought patterns flag those at highest risk
MDedge Family Medicine
Daily socialization may extend lifespan in elderly
MDedge Family Medicine
Even mild COVID is hard on the brain
MDedge Family Medicine
Childhood nightmares a prelude to cognitive problems, Parkinson’s?
MDedge Family Medicine
Mental health risks higher among young people with IBD
MDedge Family Medicine
APA releases updated eating disorder guidelines
MDedge Family Medicine
New insight into preventing antipsychotic-induced weight gain
MDedge Family Medicine
Migraine after concussion linked to worse outcomes
MDedge Family Medicine
Telehealth doctor indicted on health care fraud, opioid distribution charges
MDedge Family Medicine
Depressive symptoms tied to higher stroke risk, worse outcomes
MDedge Family Medicine